Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 22, Pages 12569
Publisher
MDPI AG
Online
2021-11-24
DOI
10.3390/ijms222212569
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival
- (2021) Takao Kamai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial
- (2021) Salomon M. Stemmer et al. Cancers
- Adenine-Based Purines and Related Metabolizing Enzymes: Evidence for Their Impact on Tumor Extracellular Vesicle Activities
- (2021) Patrizia Di Iorio et al. Cells
- Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer
- (2021) Katherine C. Kurnit et al. CANCER LETTERS
- Potential and promising anticancer drugs from adenosine and its analogs
- (2021) Shuli Man et al. DRUG DISCOVERY TODAY
- If Small Molecules Immunotherapy Comes, Can the Prime be Far Behind?
- (2021) Jingyu Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Molecular and Pharmacological Characterization of the Interaction between Human Geranylgeranyltransferase Type I and Ras-Related Protein Rap1B
- (2021) Sonja Hinz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Unraveling the Molecular Nexus between GPCRs, ERS, and EMT
- (2021) Niti Kumari et al. MEDIATORS OF INFLAMMATION
- Biological Evaluation of 5′-(N-Ethylcarboxamido)adenosine Analogues as Grp94-Selective Inhibitors
- (2021) Dilip K. Tosh et al. ACS Medicinal Chemistry Letters
- BAY 60-6583 Enhances the Antitumor Function of Chimeric Antigen Receptor-Modified T Cells Independent of the Adenosine A2b Receptor
- (2021) Jiaxing Tang et al. Frontiers in Pharmacology
- Evaluation of Combination Strategies for the A2AR Inhibitor AZD4635 Across Tumor Microenvironment Conditions via a Systems Pharmacology Model
- (2021) Veronika Voronova et al. Frontiers in Immunology
- Targeted knockdown of the adenosine A2A receptor by lipid nanoparticles rescues the chemotaxis of head and neck cancer memory T cells
- (2021) Hannah S. Newton et al. Molecular Therapy-Methods & Clinical Development
- Dual Inhibition of Ornithine Decarboxylase and A1 Adenosine Receptor Efficiently Suppresses Breast Tumor Cells
- (2021) Hongyan Ma et al. Frontiers in Oncology
- Binding Characterization of Agonists and Antagonists by MCCS: A Case Study from Adenosine A2A Receptor
- (2021) Jin Cheng et al. ACS Chemical Neuroscience
- Sevoflurane Exerts Protective Effects in Murine Peritonitis-induced Sepsis via Hypoxia-inducible Factor 1α/Adenosine A2B Receptor Signaling
- (2021) Kristian-Christos Ngamsri et al. ANESTHESIOLOGY
- Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-b-Catenin Signaling
- (2021) Hana Jin et al. Cancers
- The evolution of commercial drug delivery technologies
- (2021) Ava M. Vargason et al. Nature Biomedical Engineering
- Intestinal microbiota: A potential target for enhancing the antitumor efficacy and reducing the toxicity of immune checkpoint inhibitors
- (2021) Baohua Luo et al. CANCER LETTERS
- Biased agonism at adenosine receptors
- (2021) Samantha M. McNeill et al. CELLULAR SIGNALLING
- N ‐acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages
- (2021) Alessio Menga et al. EMBO REPORTS
- Extracellular vesicles derived from Mesenchymal Stem/Stromal Cells: the regenerative impact in liver diseases
- (2021) Adriana Psaraki et al. HEPATOLOGY
- Release of adenosine-induced immunosuppression: Comprehensive characterization of dual A2A/A2B receptor antagonist
- (2021) Katarzyna Dziedzic et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Adenosine and Inflammation: Here, There and Everywhere
- (2021) Silvia Pasquini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Subtle Chemical Changes Cross the Boundary between Agonist and Antagonist: New A3 Adenosine Receptor Homology Models and Structural Network Analysis Can Predict This Boundary
- (2021) Yoonji Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling
- (2021) Suming Pan et al. LIFE SCIENCES
- Cycling cancer persister cells arise from lineages with distinct programs
- (2021) Yaara Oren et al. NATURE
- Adenosine/TGFβ axis in regulation of mammary fibroblast functions
- (2021) Georgii Vasiukov et al. PLoS One
- MicroED structure of the human adenosine receptor determined from a single nanocrystal in LCP
- (2021) Michael W. Martynowycz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
- (2021) Lauren Giuffrida et al. Nature Communications
- Bruton’s Tyrosine Kinase and Its Isoforms in Cancer
- (2021) Xianhui Wang et al. Frontiers in Cell and Developmental Biology
- Adenosine signalling is prognostic for cancer outcome and has predictive utility for immunotherapeutic response
- (2020) Ben Sidders et al. CLINICAL CANCER RESEARCH
- Adenosine receptor blockade with ciforadenant +/- atezolizumab in advanced metastatic castration-resistant prostate cancer (mCRPC).
- (2020) Lauren Christine Harshman et al. JOURNAL OF CLINICAL ONCOLOGY
- CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma
- (2020) Xiao-Lu Ma et al. Journal of Hematology & Oncology
- Adenosine A2A receptor activation reduces brain metastasis via SDF‐1/CXCR4 axis and protecting blood‐brain barrier
- (2020) Lei Chen et al. MOLECULAR CARCINOGENESIS
- CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
- (2020) Miao Yu et al. Nature Communications
- Lessons from the A2A Adenosine Receptor Antagonist–Enabled Tumor Regression and Survival in Patients with Treatment-Refractory Renal Cell Cancer
- (2020) Michail V. Sitkovsky Cancer Discovery
- Polydeoxyribonucleotide Exerts Therapeutic Effect by Increasing VEGF and Inhibiting Inflammatory Cytokines in Ischemic Colitis Rats
- (2020) Sung-Eun Kim et al. Biomed Research International
- Control of Metastases via Myeloid CD39 and NK Cell Effector Function
- (2020) Juming Yan et al. Cancer Immunology Research
- Tumor-derived exosomes promote angiogenesis via adenosine A2B receptor signaling
- (2020) Nils Ludwig et al. ANGIOGENESIS
- Adenosine-producing regulatory B cells in head and neck cancer
- (2020) Sandra S. Jeske et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid cell-derived TGF-beta signaling regulates ECM deposition in mammary carcinoma via adenosine-dependent mechanisms
- (2020) Georgii Vasiukov et al. CANCER RESEARCH
- Impact of GPCR Structures on Drug Discovery
- (2020) Miles Congreve et al. CELL
- Corrigendum to “Adenosine augments the production of IL-10 in cervical cancer cells through interaction with the A2B adenosine receptor, resulting in protection against the activity of cytotoxic T cells” [Cytokine 130 (2020) 155082]
- (2020) Daniela Berenice Torres-Pineda et al. CYTOKINE
- Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia
- (2020) Francesca Arruga et al. HAEMATOLOGICA
- Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia
- (2020) Karolina Losenkova et al. JOURNAL OF CELL SCIENCE
- Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells
- (2020) Elham Masoumi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Moving towards personalized treatments of immune-related adverse events
- (2020) Khashayar Esfahani et al. Nature Reviews Clinical Oncology
- Adenosine leakage from perforin-burst extracellular vesicles inhibits perforin secretion by cytotoxic T-lymphocytes
- (2020) Hiroko Tadokoro et al. PLoS One
- Adenosine receptors regulate exosome production
- (2020) Nils Ludwig et al. Purinergic Signalling
- CD73 promotes colitis‑associated tumorigenesis in mice
- (2020) Xuan‑Hui Liu et al. Oncology Letters
- CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
- (2020) Jerry B. Harvey et al. Frontiers in Immunology
- Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
- (2020) Rui Yang et al. Journal for ImmunoTherapy of Cancer
- Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs
- (2020) Kenneth A. Jacobson et al. Cells
- P2Y12 receptor antagonists and AR receptor agonists regulates Protein Disulfide Isomerase secretion from platelets and endothelial cells
- (2020) Marcin Popielarski et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Assessment of biased agonism at the A3 adenosine receptor using β-arrestin and miniGαi recruitment assays
- (2020) Eline Pottie et al. BIOCHEMICAL PHARMACOLOGY
- Targeting G protein‐coupled receptors with magnetic carbon nanotubes: The A3 adenosine receptor case
- (2020) Florent Pineux et al. ChemMedChem
- Characterization of cancer-related somatic mutations in the adenosine A2B receptor
- (2020) Xuesong Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responses
- (2020) Mitra Ghasemi‐Chaleshtari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The adenosine pathway in immuno-oncology
- (2020) Bertrand Allard et al. Nature Reviews Clinical Oncology
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
- (2020) Lukas F. Mager et al. SCIENCE
- Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity
- (2020) Alexandra Borodovsky et al. Journal for ImmunoTherapy of Cancer
- Inhibition of ABCC6 Transporter Modifies Cytoskeleton and Reduces Motility of HepG2 Cells via Purinergic Pathway
- (2020) Angela Ostuni et al. Cells
- Glioma patient profiling reveals the dominant immune suppressive adenosine axis is refractory to immune function restoration
- (2020) Martina Ott et al. JCI Insight
- Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy
- (2020) Stephen M. Hatfield et al. JOURNAL OF CLINICAL INVESTIGATION
- Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
- (2020) Ali Masjedi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy
- (2020) Joseph M. Steingold et al. Frontiers in Immunology
- G protein-coupled receptors expressed and studied in yeast. The adenosine receptor as a prime example
- (2020) Xuesong Wang et al. BIOCHEMICAL PHARMACOLOGY
- ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
- (2020) Sheng Ni et al. OncoTargets and Therapy
- Involvement of CD73 and A2B Receptor in Radiation-Induced DNA Damage Response and Cell Migration in Human Glioblastoma A172 Cells
- (2020) Kazuki Kitabatake et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- PSB 603 – a known selective adenosine A2B receptor antagonist – has anti-inflammatory activity in mice
- (2020) Magdalena Kotańska et al. BIOMEDICINE & PHARMACOTHERAPY
- Extracellular Adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A3 Adenosine Receptor activation under Hypoxia
- (2019) Ángelo Torres et al. CANCER LETTERS
- Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding
- (2019) Sofia Gkountela et al. CELL
- Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development?
- (2019) Diego Guidolin et al. Frontiers in Endocrinology
- Specific Decrease in B-Cell-Derived Extracellular Vesicles Enhances Post-Chemotherapeutic CD8+ T Cell Responses
- (2019) Fanghui Zhang et al. IMMUNITY
- Exosomes in cancer development, metastasis, and immunity
- (2019) Lin Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis
- (2019) Xiao-Lu Ma et al. Journal of Hematology & Oncology
- Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1)
- (2019) Biebele Abel et al. MOLECULAR PHARMACOLOGY
- Adenosine Interaction with Adenosine Receptor A2a Promotes Gastric Cancer Metastasis by Enhancing PI3K–AKT–mTOR Signaling
- (2019) Linsen Shi et al. MOLECULAR BIOLOGY OF THE CELL
- Agonists activate different A2B adenosine receptor signaling pathways in MBA-MD-231 breast cancer cells with distinct potencies
- (2019) Marthe Koussémou et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity
- (2019) Juliana Hofstätter Azambuja et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
- (2019) Lawrence Fong et al. Cancer Discovery
- A2A and A2B adenosine receptors: The extracellular loop 2 determines high (A2A) or low affinity (A2B) for adenosine
- (2019) Elisabetta De Filippo et al. BIOCHEMICAL PHARMACOLOGY
- Involvement of adenosine A2B receptor in radiation-induced translocation of epidermal growth factor receptor and DNA damage response leading to radioresistance in human lung cancer cells
- (2019) Kazuki Kitabatake et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Involvement of A2B Receptor in DNA Damage Response and Radiosensitizing Effect of A2B Receptor Antagonists on Mouse B16 Melanoma
- (2019) Yuta Tanaka et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Adenosine Metabolism: Emerging Concepts for Cancer Therapy
- (2019) Detlev Boison et al. CANCER CELL
- Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa– induced acute lung injury and NLRP3 inflammasome activation
- (2019) Eboni D. Chambers et al. FASEB JOURNAL
- Adenosine receptor 2B activity promotes autonomous growth, migration as well as vascularization of head and neck squamous cell carcinoma cells
- (2019) Max Wilkat et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular dissection of the human A 3 adenosine receptor coupling with β-arrestin2
- (2018) Jolien Storme et al. BIOCHEMICAL PHARMACOLOGY
- New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism
- (2018) Elizabeth A Vecchio et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting the CD73-adenosine axis in immuno-oncology
- (2018) David Allard et al. IMMUNOLOGY LETTERS
- A2AAdenosine Receptor Gene Deletion or Synthetic A2AAntagonist Liberate Tumor-Reactive CD8+T Cells from Tumor-Induced Immunosuppression
- (2018) Jorgen Kjaergaard et al. JOURNAL OF IMMUNOLOGY
- Biased signalling: from simple switches to allosteric microprocessors
- (2018) Jeffrey S. Smith et al. NATURE REVIEWS DRUG DISCOVERY
- Pharmacology of Adenosine Receptors: The State of the Art
- (2018) Pier Andrea Borea et al. PHYSIOLOGICAL REVIEWS
- CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
- (2018) Limo Chen et al. Cancer Discovery
- Hypoxia enhances indoleamine 2,3-dioxygenase production in dendritic cells
- (2018) Xiang Song et al. Oncotarget
- The A2B Adenosine Receptor Modulates the Epithelial– Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells
- (2018) Chiara Giacomelli et al. Frontiers in Pharmacology
- CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
- (2018) Michela Lupia et al. Stem Cell Reports
- Targeting the IDO1 pathway in cancer: from bench to bedside
- (2018) Ming Liu et al. Journal of Hematology & Oncology
- The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1
- (2018) Marthe Koussémou et al. PLoS One
- Accurate measurement of endogenous adenosine in human blood
- (2018) Lars Löfgren et al. PLoS One
- Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
- (2018) Jie Lan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti–PD-(L)1 and Anti–CTLA-4 in Preclinical Models
- (2018) Stephen B. Willingham et al. Cancer Immunology Research
- Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers
- (2018) Lisa Seitz et al. INVESTIGATIONAL NEW DRUGS
- Ecto-5′-nucleotidase (CD73) is a potential target of hepatocellular carcinoma
- (2018) Shalaimaiti Shali et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway
- (2017) Seyyed Mehdi Jafari et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Polypharmacology of N6-(3-Iodobenzyl)adenosine-5′-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic Potential
- (2017) Jinha Yu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Impact of G protein-coupled receptor heteromers in endocrine systems
- (2017) K.C. Jonas et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Adenosine receptors: Modulators of lipid availability that are controlled by lipid levels
- (2017) Andrea Leiva et al. MOLECULAR ASPECTS OF MEDICINE
- Metabolic Interactions in the Tumor Microenvironment
- (2017) Costas A. Lyssiotis et al. TRENDS IN CELL BIOLOGY
- Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation
- (2017) Yiming Xu et al. Nature Communications
- Engineering cell sensing and responses using a GPCR-coupled CRISPR-Cas system
- (2017) Nathan H. Kipniss et al. Nature Communications
- A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation
- (2017) Seyyed Mehdi Jafari et al. CELLULAR ONCOLOGY
- Human Adenosine A2A Receptor: Molecular Mechanism of Ligand Binding and Activation
- (2017) Byron Carpenter et al. Frontiers in Pharmacology
- Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs
- (2016) Gemma Navarro et al. BMC BIOLOGY
- GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling
- (2016) Alex R.B. Thomsen et al. CELL
- The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias
- (2016) Ajith A. Welihinda et al. CELLULAR SIGNALLING
- SOX2, OCT3/4 and NANOG expression and cellular plasticity in rare human somatic cells requires CD73
- (2016) Deng Pan et al. CELLULAR SIGNALLING
- A2A-D2 receptor-receptor interaction modulates gliotransmitter release from striatal astrocyte processes
- (2016) Chiara Cervetto et al. JOURNAL OF NEUROCHEMISTRY
- Role of Increased n-acetylaspartate Levels in Cancer
- (2016) Behrouz Zand et al. JNCI-Journal of the National Cancer Institute
- Equilibrative nucleoside transporters—A review
- (2016) Rebba C. Boswell-Casteel et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Damage-associated molecular patterns in cancer: a double-edged sword
- (2016) C Hernandez et al. ONCOGENE
- Protein kinase A–dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1
- (2016) John W. Bullen et al. Science Signaling
- Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
- (2016) Pier Andrea Borea et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Adenosine A3 receptor elicits chemoresistance mediated by multiple resistance-associated protein-1 in human glioblastoma stem-like cells
- (2016) Angelo Torres et al. Oncotarget
- Role of Increased n-acetylaspartate Levels in Cancer
- (2016) Behrouz Zand et al. JNCI-Journal of the National Cancer Institute
- Protein kinase A–dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1
- (2016) John W. Bullen et al. Science Signaling
- Lymphatic transport of exosomes as a rapid route of information dissemination to the lymph node
- (2016) Swetha Srinivasan et al. Scientific Reports
- Nuclear factor of activated T cells in cancer development and treatment
- (2015) Jiawei Shou et al. CANCER LETTERS
- Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker
- (2015) T.-F. Lou et al. Cancer Prevention Research
- Adenosine A2B receptor stimulates angiogenesis by inducing VEGF and eNOS in human microvascular endothelial cells
- (2015) Xiaolong Du et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Loss of CD73-mediated actin polymerization promotes endometrial tumor progression
- (2015) Jessica L. Bowser et al. JOURNAL OF CLINICAL INVESTIGATION
- p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death
- (2015) J S Long et al. ONCOGENE
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Dysregulation of gene expression in ABCC6 knockdown HepG2 cells
- (2014) Rocchina Miglionico et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities
- (2014) Gennady G. Yegutkin CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor
- (2014) Tian-zhu Liu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Enhanced Antitumor Effects of Adenoviral-Mediated siRNA against GRP78 Gene on Adenosine-Induced Apoptosis in Human Hepatoma HepG2 Cells
- (2014) Ling-Fei Wu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
- (2014) Estefanía Moreno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adenosine Regulates the Proinflammatory Signaling Function of Thrombin in Endothelial Cells
- (2014) Seyed Mahdi Hassanian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Smad and NFAT Pathways Cooperate To Induce CD103 Expression in Human CD8 T Lymphocytes
- (2014) M. Mokrani et al. JOURNAL OF IMMUNOLOGY
- Role of TGF-β Signaling in Generation of CD39+CD73+Myeloid Cells in Tumors
- (2014) Sergey V. Ryzhov et al. JOURNAL OF IMMUNOLOGY
- Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
- (2014) Stephen M. Hatfield et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy
- (2014) S Daniele et al. Cell Death & Disease
- Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
- (2014) A. Young et al. Cancer Discovery
- Hostile, Hypoxia-A2-Adenosinergic Tumor Biology as the Next Barrier to Overcome for Tumor Immunologists
- (2014) M. V. Sitkovsky et al. Cancer Immunology Research
- The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors
- (2013) Benjamin F. Seibt et al. BIOCHEMICAL PHARMACOLOGY
- CD73 expression on extracellular vesicles derived from CD4+CD25+Foxp3+T cells contributes to their regulatory function
- (2013) Lesley Ann Smyth et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
- (2013) Rebecca L. Williams-Karnesky et al. JOURNAL OF CLINICAL INVESTIGATION
- Extracellular Adenosine Sensing—A Metabolic Cell Death Priming Mechanism Downstream of p53
- (2013) Jaclyn S. Long et al. MOLECULAR CELL
- Adenosine receptors as drug targets — what are the challenges?
- (2013) Jiang-Fan Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Adenosine Stimulates the Migration of Human Endothelial Progenitor Cells. Role ofCXCR4 and MicroRNA-150
- (2013) Magali Rolland-Turner et al. PLoS One
- Rare somatic cells from human breast tissue exhibit extensive lineage plasticity
- (2013) S. Roy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Adenosine-Mediated Signaling Pathway Suppresses Prenylation of the GTPase Rap1B and Promotes Cell Scattering
- (2013) E. Ntantie et al. Science Signaling
- CD39 and CD73 in immunity and inflammation
- (2013) Luca Antonioli et al. TRENDS IN MOLECULAR MEDICINE
- Regulation of Neutrophil Function by Adenosine
- (2012) Kathryn E. Barletta et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apoptosis induced by adenosine involves endoplasmic reticulum stress in EC109 cells
- (2012) LING-FEI WU et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis
- (2012) Carmen Chak-Lui Wong et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors
- (2012) Kyle Jensen et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release
- (2012) S. Park et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5′-n-methyluronamide in human leukemia cells
- (2011) Petr Mlejnek et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
- (2011) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update
- (2011) B. B. Fredholm et al. PHARMACOLOGICAL REVIEWS
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- Physiological and pathophysiological roles of adenosine
- (2011) Bertil B FREDHOLM Sleep and Biological Rhythms
- Adenosine up-regulates vascular endothelial growth factor in human macrophages
- (2010) Isabelle Ernens et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors
- (2010) Stefania Gessi et al. BIOCHEMICAL PHARMACOLOGY
- Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death
- (2010) Leonóra Himer et al. FASEB JOURNAL
- Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B Receptor
- (2010) Kengo Moriyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inactivation of Adenosine A2AReceptor Attenuates Basal and Angiotensin II-induced ROS Production by Nox2 in Endothelial Cells
- (2010) Sapna Thakur et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver
- (2010) S. Cohen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Tissue architecture and function: dynamic reciprocity via extra- and intra-cellular matrices
- (2009) Ren Xu et al. CANCER AND METASTASIS REVIEWS
- Rab27a and Rab27b control different steps of the exosome secretion pathway
- (2009) Matias Ostrowski et al. NATURE CELL BIOLOGY
- T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
- (2009) Michail V. Sitkovsky TRENDS IN IMMUNOLOGY
- Adenosine receptors in regulation of dendritic cell differentiation and function
- (2008) S. V. Novitskiy et al. BLOOD
- Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy
- (2008) Masuko Ushio-Fukai et al. CANCER LETTERS
- An antagonistic interaction between A2Badenosine and D2dopamine receptors modulates the function of rat carotid body chemoreceptor cells
- (2008) Silvia V. Conde et al. JOURNAL OF NEUROCHEMISTRY
- Regulation of A1adenosine receptor functioning induced by P2Y1purinergic receptor activation in human astroglial cells
- (2008) I. Tonazzini et al. JOURNAL OF NEUROSCIENCE RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More